SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.00+8.5%Dec 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (1715)9/21/2000 3:45:45 PM
From: Biomaven  Read Replies (3) of 52153
 
As I look at the high prices in the biotech upper tiers, I am increasingly attracted to the more neglected small stocks. (Hi, Rick and Mike! <g>). I don't yet have the guts to ever place much of a bet on any one of them, but maybe I'll yet develop a taste. Hoping I'm not in for some aversive taste therapy here, though. <g>

Some good examples are FOCL, INKP, and CDIC, the latter two of which had good news today that the market mostly seems to have ignored. (Maybe that's why this sort of stock makes for a frustrating life?). KDUS too is a good buy at these levels, given it is effectively trading below cash.

Here's the INKP news:

InKine Pharmaceutical Announces FDA Approval of Visicol(TM) Tablets; At Market Early 2001

biz.yahoo.com

This stuff is clearly as effective as Golytely and its cohorts, but much more pleasant to take and has markedly fewer side effects to boot. Not exactly going to be a billion dollar drug, but should have a good effect on a small company like INKP.

Here's the CDIC news:

CardioDynamics (CDIC) Reports Eleventh Consecutive Quarterly Sales Increase and 72% Growth for Third Quarter 2000

biz.yahoo.com

Good looking results, particularly as I was worried that last quarter was pumped some by non-recurring sales.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext